Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 02, 2020 02:12 ET | Source: APEIRON Biologics

APEIRON Biologics Initiates Phase II Clinical Trial of APN01 for Treatment of COVID-19

Regulatory approvals obtained for the treatment of 200 COVID-19 patients in Austria, Germany and Denmark; Austrian government to provide significant financial supportAPN01 has the potential to block...